Capital Market and Enterprise Core Competitiveness Interaction Mechanism—Based on the Case of Kangmei Pharmaceutical Co., Ltd ()
ABSTRACT
Since the establishment of China’s capital market, it has been imperfect.
Many listed companies misappropriating the capital market, and some of them
want to expand the size through the capital market. It seems that enhance
corporate value is impossible, too. However, companies want bigger and stronger
cannot do without a strong leverage of the capital market, and enterprises to
enhance their value can be counterproductive in the capital markets, improve
the efficiency of capital markets. This paper analyzes Kangmei Pharmaceutical
Co., Ltd, and the relationship between its financing and value growth in the
Chinese capital market, research results exist mutually reinforcing mechanisms
between capital market efficiency and core competitiveness of enterprises.
Share and Cite:
Zou, B. (2015) Capital Market and Enterprise Core Competitiveness Interaction Mechanism—Based on the Case of Kangmei Pharmaceutical Co., Ltd.
Modern Economy,
6, 465-472. doi:
10.4236/me.2015.64044.